General Rules

We welcome submissions relevant to any aspect of lung cancer and will be divided into the following categories:

1. Basic science
2. Translational research
3. Clinical research

Abstract Guidelines

Please take note of the following:

• Abstracts should be written in English and include the following subheadings:
  • Title
  • Background
  • Materials and Methods
  • Results
  • Conclusions
• There is no limit to number of authors, but the presenting author should be clearly indicated (underlined). Names, institutional affiliations, cities and countries of all contributing authors should be provided, and all correspondence will be made through the submitting author.
• All accepted abstracts will be presented in poster format and further instructions will be available nearer the conference date.
• Abstract text should not exceed 300 words (excluding list of authors or references).

Topics

Topics are welcome from any discipline involved in the care and study of lung cancer including but not limited to:

• Pathogenesis of lung cancer
• Diagnostic techniques in lung cancer
• Lung cancer genomics and other high throughput “omics” studies
• Biomarkers
• Novel therapeutics and clinical trials
• Supportive care
• Cancer prevention
• Lung cancer screening
• Health economics
• Tobacco control
• In vitro and in vivo models
• Current Therapeutics
• Immunotherapy